HPV Vaccine Highly Effective in Girls Years Later

HPV Vaccine Highly Effective in Girls Years Later

TOPLINE: The vaccine Cervarix was effective in protecting women from cervical cancer when administered between ages 12 and 13 years, according to a new study published in Journal of the National Cancer Institute. METHODOLOGY: Cervical cancer is the fourth most common cancer among women worldwide. Programs to provide Cervarix, a bivalent vaccine, began in the …

Read more

Impressive Bleeding Profile With Factor XI Inhibitor in AF

Impressive Bleeding Profile With Factor XI Inhibitor in AF

xFurther details from the phase 2b AZALEA trial with the factor XI inhibitor abelacimab (Anthos) show significant reductions in major and clinically relevant nonmajor bleeding compared with rivaroxaban for patients with AF; the risk of stroke was moderate to high. The trial was stopped earlier this year because of an “overwhelming” reduction in bleeding with …

Read more